NextGen 2024: Genetics in SJIA Session Part 1

NextGen 2024: Genetics in SJIA Session Part 1

@SJIA_Foundation
@SJIA_Foundation
8 Followers
2 weeks ago 90

NextGen 2024: Genetics in SJIA Session Part 1

@SJIA_Foundation2 weeks ago

“Clinical Utility of Genetics 
in Systemic JIA” 
Randy Q. Cron, MD, PhD
University of Alabama at…
1/12
Disclosures 
Randy Q. Cron, M.D., Ph.D.
SOBI – investigator initiated clinical trial of anakinra …
2/12
Natural killer cell dysfunction in patients with systemic-onset 
juvenile rheumatoid arthritis and…
3/12
Macrophage activation syndrome in patients with systemic 
juvenile idiopathic arthritis is associa…
4/12
Novel UNC13D intronic variant disrupting a NFκB enhancer in a patient with recurrent 
macrophage a…
5/12
Vastert
PRF1 A91V mutation
sJIA/MAS – 20%
vs.
sJIA no MAS – 10%
6/12
Pt Age Sex Diagnosis Trigger Gene Mutation Amino Acid 
Change
Prior 
Association
Outcome
1 15 …
7/12
Heterozygous FHL
gene mutations:
5/14 sJIA/MAS – 36%
vs.
4/29 sJIA no MAS – 
14%
Kaufman
8/12
Role of DOCK8 in Cytokine Storm Syndromes.
Zhang M, Cron RR, Chu N, Nguyen J, Gordon SM, Eloseily …
9/12
Ombrello
10/12
MAS Genetics in Systemic JIA
Schulert
Lee
11/12
Value of genetic knowledge in 
sJIA/MAS
•IRF5, IL1RN, HLA-DRB1*15 - Ombrello
•HLH gene associati…
12/12


  • Previous
  • Next
  • f Fullscreen
  • esc Exit Fullscreen
@SJIA_Foundation

Share

NextGen 2024: Genetics in SJIA Session Part 1

Embed code


Swipe LEFT
to view Related

Scroll DOWN
to read doc

This website uses cookies to improve your experience. By using this site, you consent to the use of cookies.

Login

OR

Forgot password?

Don't have an account? Sign Up